Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin PK and ABCB1 Polymorphism in Bangladeshi Volunteers
NCT05437783Phase 1Unknown
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jan 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of azithromycin in bacterial infection (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoints: Maximum Plasma Concentration at 72 hours, Area Under the Curve from time 0 to last measurable concentration at 72 hours and 1 more. Status: unknown.
02
Drugs
azithromycin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05437783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05437783.